Table 2.
Distribution of the most prevalent adenovirus hexon sequence genotypes among specimens from the studied civilians.
| Total no. of specimens | Adenovirus type, no. (%) of specimens |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Variable | 1 (n = 284) | 2 (n = 390) | 3 (n = 556) | 4 (n = 78) | 5 (n = 86) | 7 (n = 48) | 21 (n = 32) | 41 (n = 29) | Other (n = 105) | |
| Collection year | ||||||||||
| 2004 | 307 | 40 (13) | 69 (22.5) | 132 (43) | 20 (6.5) | 20 (6.5) | 0 (0) | 3 (1) | 3 (1) | 20 (6.5) |
| 2005 | 846 | 153 (18.1) | 212 (25.1) | 293 (34.6) | 34 (4) | 45 (5.3) | 23 (2.7) | 18 (2.1) | 18 (2.1) | 50 (5.9) |
| 2006 | 455 | 91 (20) | 109 (24) | 131 (28.8) | 24 (5.3) | 21 (4.6) | 25 (5.5) | 11 (2.4) | 8 (1.8) | 35 (7.7) |
| Collection month | ||||||||||
| January | 197 | 32 (16.2) | 48 (24.4) | 71 (36) | 6 (3) | 8 (4.1) | 8 (4.1) | 2 (1) | 6 (3) | 16 (8.1) |
| February | 163 | 39 (23.9) | 34 (20.9) | 56 (34.4) | 5 (3.1) | 11 (6.7) | 4 (2.5) | 3 (1.8) | 4 (2.5) | 7 (4.3) |
| March | 168 | 33 (19.6) | 44 (26.2) | 50 (29.8) | 7 (4.2) | 7 (4.2) | 6 (3.6) | 3 (1.8) | 3 (1.8) | 15 (8.9) |
| April | 141 | 31 (22) | 38 (27) | 39 (27.7) | 6 (4.3) | 10 (7.1) | 6 (4.3) | 3 (2.1) | 0 (0) | 8 (5.7) |
| May | 95 | 14 (14.7) | 24 (25.3) | 28 (29.5) | 7 (7.4) | 3 (3.2) | 6 (6.3) | 11 (11.6) | 2 (2.1) | 0 (0) |
| June | 105 | 18 (17.1) | 24 (22.9) | 37 (35.2) | 6 (5.7) | 8 (7.6) | 1 (1) | 3 (2.9) | 1 (1) | 7 (6.7) |
| July | 102 | 11 (10.8) | 28 (27.5) | 40 (39.2) | 5 (4.9) | 3 (2.9) | 2 (2) | 2 (2) | 4 (3.9) | 7 (6.9) |
| August | 106 | 8 (7.5) | 18 (17) | 42 (39.6) | 15 (14.2) | 7 (6.6) | 4 (3.8) | 1 (0.9) | 1 (0.9) | 10 (9.4) |
| September | 77 | 17 (22.1) | 10 (13) | 32 (41.6) | 7 (9.1) | 3 (3.9) | 2 (2.6) | 0 (0) | 0 (0) | 6 (7.8) |
| October | 84 | 17 (20.2) | 14 (16.7) | 30 (35.7) | 5 (6) | 6 (7.1) | 2 (2.4) | 0 (0) | 3 (3.6) | 7 (8.3) |
| November | 189 | 35 (18.5) | 48 (25.4) | 68 (36) | 4 (2.1) | 13 (6.9) | 3 (1.6) | 3 (1.6) | 1 (0.5) | 14 (7.4) |
| December | 181 | 29 (16) | 60 (33.1) | 63 (34.8) | 5 (2.8) | 7 (3.9) | 4 (2.2) | 1 (0.6) | 4 (2.2) | 8 (4.4) |
| Patient age group | ||||||||||
| <7 years | 1235 | 253 (20.5) | 334 (27) | 419 (33.9) | 38 (3.1) | 64 (5.2) | 34 (2.8) | 13 (1.1) | 25 (2) | 55 (4.5) |
| ≥7 years | 373 | 31 (8.3) | 56 (15) | 137 (36.7) | 40 (10.7) | 22 (5.9) | 14 (3.8) | 19 (5.1) | 4 (1.1) | 50 (13.4) |
| Patient sex | ||||||||||
| Male | 948 | 182 (19.2) | 228 (24.1) | 305 (32.2) | 53 (5.6) | 49 (5.2) | 27 (2.8) | 21 (2.2) | 12 (1.3) | 71 (7.5) |
| Female | 653 | 102 (15.6) | 156 (23.9) | 251 (38.4) | 25 (3.8) | 37 (5.7) | 21 (3.2) | 11 (1.7) | 16 (2.5) | 34 (5.2) |
| Collection site | ||||||||||
| New Haven, CT | 201 | 44 (21.9) | 33 (16.4) | 70 (34.8) | 19 (9.5) | 15 (7.5) | 4 (2) | 9 (4.5) | 0 (0) | 7 (3.5) |
| Indianapolis, IN | 178 | 27 (15.2) | 30 (16.9) | 57 (32) | 3 (1.7) | 18 (10.1) | 9 (5.1) | 0 (0) | 9 (5.1) | 25 (14) |
| St. Louis, MO | 178 | 42 (23.6) | 47 (26.4) | 60 (33.7) | 7 (3.9) | 12 (6.7) | 1 (0.6) | 6 (3.4) | 0 (0) | 3 (1.7) |
| Denver, CO | 162 | 40 (24.7) | 44 (27.2) | 36 (22.2) | 6 (3.7) | 4 (2.5) | 6 (3.7) | 2 (1.2) | 5 (3.1) | 19 (11.7) |
| Houston, TX | 138 | 16 (11.6) | 50 (36.2) | 44 (31.9) | 9 (6.5) | 6 (4.3) | 3 (2.2) | 0 (0) | 3 (2.2) | 7 (5.1) |
| Manhasset, NY | 120 | 16 (13.3) | 33 (27.5) | 50 (41.7) | 14 (11.7) | 3 (2.5) | 1 (0.8) | 1 (0.8) | 0 (0) | 2 (1.7) |
| Tempe, AZ | 119 | 19 (16) | 24 (20.2) | 60 (50.4) | 2 (1.7) | 3 (2.5) | 6 (5) | 1 (0.8) | 1 (0.8) | 3 (2.5) |
| Kansas City, MO | 107 | 8 (7.5) | 12 (11.2) | 68 (63.6) | 3 (2.8) | 2 (1.9) | 6 (5.6) | 0 (0) | 3 (2.8) | 5 (4.7) |
| Milwaukee, WI | 103 | 11 (10.7) | 43 (41.7) | 19 (18.4) | 0 (0) | 6 (5.8) | 1 (1) | 0 (0) | 5 (4.9) | 18 (17.5) |
| Nashville, TN | 78 | 7 (9) | 16 (20.5) | 27 (34.6) | 3 (3.8) | 3 (3.8) | 1 (1.3) | 11 (14.1) | 1 (1.3) | 9 (11.5) |
| Seattle, WA | 73 | 10 (13.7) | 18 (24.7) | 30 (41.1) | 3 (4.1) | 6 (8.2) | 0 (0) | 0 (0) | 1 (1.4) | 5 (6.8) |
| Chapel Hill, NC | 69 | 24 (34.8) | 17 (24.6) | 10 (14.5) | 5 (7.2) | 4 (5.8) | 7 (10.1) | 0 (0) | 0 (0) | 2 (2.9) |
| Syracuse, NY | 54 | 18 (33.3) | 16 (29.6) | 10 (18.5) | 4 (7.4) | 3 (5.6) | 1 (1.9) | 1 (1.9) | 1 (1.9) | 0 (0) |
| Jacksonville, FL | 28 | 2 (7.1) | 7 (25) | 15 (53.6) | 0 (0) | 1 (3.6) | 2 (7.1) | 1 (3.6) | 0 (0) | 0 (0) |
| Specimen source | ||||||||||
| Upper respiratory tract | 1142 | 215 (18.8) | 282 (24.7) | 461 (40.4) | 57 (5) | 55 (4.8) | 26 (2.3) | 21 (1.8) | 2 (0.2) | 23 (2) |
| Lower respiratory tract | 58 | 6 (10.3) | 12 (20.7) | 16 (27.6) | 5 (8.6) | 5 (8.6) | 1 (1.7) | 6 (10.3) | 1 (1.7) | 6 (0.1) |
| Gastrointestinal tract | 234 | 34 (14.5) | 65 (27.8) | 36 (15.4) | 10 (4.3) | 20 (8.6) | 6 (2.6) | 3 (1.3) | 26 (11.1) | 34 (0.1) |
| Urine | 44 | 2 (4.6) | 6 (13.6) | 3 (6.8) | 1 (2.3) | 2 (4.6) | 4 (9.1) | 0 (0) | 0 (0) | 26 (0.6) |
| Blood | 37 | 18 (48.7) | 7 (18.9) | 2 (5.4) | 0 (0) | 2 (5.4) | 6 (16.2) | 0 (0) | 0 (0) | 2 (0.1) |
| Ocular | 36 | 0 (0) | 1 (2.8) | 22 (61.1) | 3 (8.3) | 0 (0) | 1 (2.8) | 1 (2.8) | 0 (0) | 8 (0.2) |
| Othera | 57 | 9 (15.8) | 17 (29.8) | 16 (28.1) | 2 (3.5) | 2 (3.5) | 4 (7) | 1 (1.8) | 0 (0) | 6 (0.1) |
| Patient hospitalized when culture obtained | ||||||||||
| Yes | 798 | 115 (14.4) | 198 (24.8) | 247 (31) | 40 (5) | 49 (6.1) | 28 (3.5) | 26 (3.3) | 20 (2.5) | 75 (9.4) |
| No | 718 | 155 (21.6) | 171 (23.8) | 269 (37.5) | 35 (4.9) | 32 (4.5) | 15 (2.1) | 6 (0.8) | 9 (1.3) | 26 (3.6) |
| Uncertain | 92 | 14 (15.2) | 21 (22.8) | 40 (43.5) | 3 (3.3) | 5 (5.4) | 5 (5.4) | 0 (0) | 0 (0) | 4 (4.3) |
NOTE. Counts occasionally include multiple isolates from a single clinical event. Because of missing data, total counts are not always identical.
a
Includes CSF, lymph nodes, combined sources, and no source indicated.